Norris Medicines Live BSE/NSE | Norris Medicines Fundamenta data | Norris Medicines Balance sheet | Norris Medicines Quarterly Results | Norris Medicines Profit & Loss

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

6.00
N/A
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

20.14
N/A
-1.52

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
-2.72
-7.35

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
-
54.19

PAT CAGR (%)

10 Years
5 Years
3 Years

-
10.07
29.70

P:E (Median)

8 Years
5 Years
3 Years

P:BV (Average)

8 Years
5 Years
3 Years

-
-
-1.68

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
-
-22.08

Quarterly Results

Standalone Figures in Rs. Crores

Description Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var%
Net Sales 3.17 1.76 80.11% 1.84 2.96 -37.84% 1.36 3.57 -61.90% 1.76 4.11 -57.18%
Expenses 4.00 2.48 61.29% 1.83 3.10 -40.97% 2.27 2.69 -15.61% 2.15 4.72 -54.45%
EBITDA -0.84 -0.72 - 0.01 -0.13 - -0.91 0.88 - -0.39 -0.61 -
EBIDTM -26.41% -40.97% 0.76% -4.56% -67.33% 24.69% -21.87% -14.83%
Other Income 0.00 0.00 0.00 0.03 0.01 200.00% 0.08 0.04 100.00% 0.00 0.00 0.00
Interest 0.28 0.19 47.37% 0.11 0.18 -38.89% 0.36 0.19 89.47% 0.16 0.18 -11.11%
Depreciation 0.18 0.18 0.00% 0.18 0.18 0.00% 0.20 0.19 5.26% 0.18 0.18 0.00%
PBT -1.29 -1.09 - -0.25 -0.48 - -1.39 0.54 - -0.72 -0.96 -
Tax 0.00 0.00 0.00 0.00 0.00 0.00 -0.84 -0.33 - 0.00 0.00 0.00
PAT -1.29 -1.09 - -0.25 -0.48 - -0.55 0.88 - -0.72 -0.96 -
PATM -40.85% -62.05% -13.68% -16.23% -40.56% 24.61% -40.74% -23.41%
EPS -1.29 -1.09 - -0.25 -0.48 - -0.55 0.88 - -0.72 -0.96 -

Description Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var%
Net Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Expenses 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBITDA 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Annual Results

Standalone Figures in Rs. Crores

Description TTM Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Net Sales 8.13 16.27 13.57 20.46 18.86 18.68 20.70 21.41 15.68 Net Sales Growth -34.44% 19.90% -33.68% 8.48% 0.96% -9.76% -3.32% 36.54% Cost Of Goods Sold 5.30 6.39 3.43 10.40 9.30 9.12 13.68 13.07 8.33 Gross Profit 2.83 9.89 10.14 10.06 9.56 9.56 7.02 8.34 7.35 GP Margin 34.76% 60.79% 74.72% 49.17% 50.69% 51.18% 33.91% 38.95% 46.88% Total Expenditure 10.25 16.88 15.49 20.53 18.02 16.97 21.76 20.27 14.01 Power & Fuel Cost - 1.54 1.62 1.63 1.68 1.63 1.40 1.33 1.13 % Of Sales - 9.47% 11.94% 7.97% 8.91% 8.73% 6.76% 6.21% 7.21% Employee Cost - 3.81 4.93 5.31 4.84 4.08 3.70 3.26 2.33 % Of Sales - 23.42% 36.33% 25.95% 25.66% 21.84% 17.87% 15.23% 14.86% Manufacturing Exp. - 4.41 4.30 1.76 1.08 0.81 1.64 0.93 0.35 % Of Sales - 27.11% 31.69% 8.60% 5.73% 4.34% 7.92% 4.34% 2.23% General & Admin Exp. - 0.68 1.11 1.23 0.92 0.84 0.91 1.12 0.64 % Of Sales - 4.18% 8.18% 6.01% 4.88% 4.50% 4.40% 5.23% 4.08% Selling & Distn. Exp. - 0.06 0.08 0.12 0.19 0.48 0.41 0.50 0.11 % Of Sales - 0.37% 0.59% 0.59% 1.01% 2.57% 1.98% 2.34% 0.70% Miscellaneous Exp. - 0.01 0.01 0.08 0.01 0.01 0.01 0.05 1.11 % Of Sales - 0.06% 0.07% 0.39% 0.05% 0.05% 0.05% 0.23% 7.08% EBITDA -2.13 -0.61 -1.92 -0.07 0.84 1.71 -1.06 1.14 1.67 EBITDA Margin -26.20% -3.75% -14.15% -0.34% 4.45% 9.15% -5.12% 5.32% 10.65% Other Income 0.11 0.04 0.14 0.14 0.30 0.15 0.12 0.03 0.02 Interest 0.91 0.73 0.70 0.60 0.67 0.54 0.45 0.03 0.07 Depreciation 0.74 0.71 0.71 0.65 0.60 1.31 1.17 1.07 1.03 PBT -3.65 -2.01 -3.18 -1.18 -0.14 0.01 -2.56 0.07 0.60 Tax -0.84 -0.33 -0.67 -0.42 -0.18 1.05 -1.10 0.00 0.52 Tax Rate 23.01% 16.42% 21.07% 35.59% 128.57% 10500.00% 42.97% 0.00% 86.67% PAT -2.81 -1.68 -2.51 -0.77 0.04 -1.04 -1.45 -0.09 0.08 PAT before Minority Interest -2.81 -1.68 -2.51 -0.77 0.04 -1.04 -1.45 -0.09 0.08 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -34.56% -10.33% -18.50% -3.76% 0.21% -5.57% -7.00% -0.42% 0.51% PAT Growth 0.00% 33.07% -225.97% -2025.00% 103.85% 28.28% -1511.11% -212.50% Unadjusted EPS -2.81 -1.68 -2.51 -0.77 0.04 -1.04 -1.45 -0.09 0.08

Description

TTM

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Net Sales

8.13

16.27

13.57

20.46

18.86

18.68

20.70

21.41

15.68

Net Sales Growth

-34.44%

19.90%

-33.68%

8.48%

0.96%

-9.76%

-3.32%

36.54%

Cost Of Goods Sold

5.30

6.39

3.43

10.40

9.30

9.12

13.68

13.07

8.33

Gross Profit

2.83

9.89

10.14

10.06

9.56

7.02

8.34

7.35

GP Margin

34.76%

60.79%

74.72%

49.17%

50.69%

51.18%

33.91%

38.95%

46.88%

Total Expenditure

10.25

16.88

15.49

20.53

18.02

16.97

21.76

20.27

14.01

Power & Fuel Cost

1.54

1.62

1.63

1.68

1.63

1.40

1.33

1.13

% Of Sales

9.47%

11.94%

7.97%

8.91%

8.73%

6.76%

6.21%

7.21%

Employee Cost

3.81

4.93

5.31

4.84

4.08

3.70

3.26

2.33

% Of Sales

23.42%

36.33%

25.95%

25.66%

21.84%

17.87%

15.23%

14.86%

Manufacturing Exp.

4.41

4.30

1.76

1.08

0.81

1.64

0.93

0.35

% Of Sales

27.11%

31.69%

8.60%

5.73%

4.34%

7.92%

4.34%

2.23%

General & Admin Exp.

0.68

1.11

1.23

0.92

0.84

0.91

1.12

0.64

% Of Sales

4.18%

8.18%

6.01%

4.88%

4.50%

4.40%

5.23%

4.08%

Selling & Distn. Exp.

0.06

0.08

0.12

0.19

0.48

0.41

0.50

0.11

% Of Sales

0.37%

0.59%

1.01%

2.57%

1.98%

2.34%

0.70%

Miscellaneous Exp.

0.01

0.08

0.01

0.05

1.11

% Of Sales

0.06%

0.07%

0.39%

0.05%

0.23%

7.08%

EBITDA

-2.13

-0.61

-1.92

-0.07

0.84

1.71

-1.06

1.14

1.67

EBITDA Margin

-26.20%

-3.75%

-14.15%

-0.34%

4.45%

9.15%

-5.12%

5.32%

10.65%

Other Income

0.11

0.04

0.14

0.30

0.15

0.12

0.03

0.02

Interest

0.91

0.73

0.70

0.60

0.67

0.54

0.45

0.03

0.07

Depreciation

0.74

0.71

0.65

0.60

1.31

1.17

1.07

1.03

PBT

-3.65

-2.01

-3.18

-1.18

-0.14

0.01

-2.56

0.07

0.60

Tax

-0.84

-0.33

-0.67

-0.42

-0.18

1.05

-1.10

0.00

0.52

Tax Rate

23.01%

16.42%

21.07%

35.59%

128.57%

10500.00%

42.97%

0.00%

86.67%

PAT

-2.81

-1.68

-2.51

-0.77

0.04

-1.04

-1.45

-0.09

0.08

PAT before Minority Interest

-2.81

-1.68

-2.51

-0.77

0.04

-1.04

-1.45

-0.09

0.08

Minority Interest

0.00

PAT Margin

-34.56%

-10.33%

-18.50%

-3.76%

0.21%

-5.57%

-7.00%

-0.42%

0.51%

PAT Growth

0.00%

33.07%

-225.97%

-2025.00%

103.85%

28.28%

-1511.11%

-212.50%

Unadjusted EPS

-2.81

-1.68

-2.51

-0.77

0.04

-1.04

-1.45

-0.09

0.08

Results Balance Sheet

Standalone Figures in Rs. Crores

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Shareholder's Funds 0.37 2.05 4.56 5.33 5.29 6.35 7.80 7.89 Share Capital 9.93 9.93 9.93 9.93 9.93 9.93 9.93 9.93 Total Reserves -9.55 -7.88 -5.36 -4.60 -4.63 -3.58 -2.12 -2.04 Non-Current Liabilities 8.43 5.23 5.76 6.09 6.27 5.07 5.71 1.08 Secured Loans 0.00 0.02 0.08 0.00 0.00 0.00 0.00 0.22 Unsecured Loans 11.24 7.69 7.49 7.49 7.49 7.34 6.88 2.19 Long Term Provisions 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Liabilities 8.77 10.92 9.91 5.09 5.37 7.64 7.99 6.91 Trade Payables 3.90 4.73 3.57 2.54 2.79 5.66 6.46 3.18 Other Current Liabilities 0.60 1.67 1.96 1.87 0.98 1.10 0.97 0.58 Short Term Borrowings 2.96 3.55 3.71 0.02 0.67 0.19 0.18 2.81 Short Term Provisions 1.32 0.98 0.67 0.66 0.93 0.70 0.38 0.33 Total Liabilities 17.57 18.20 20.23 16.51 16.93 19.06 21.50 15.88 Net Block 8.90 9.32 9.97 8.34 8.61 8.97 7.94 8.18 Gross Block 27.70 27.41 27.85 25.63 25.30 24.34 22.14 21.31 Accumulated Depreciation 18.80 18.09 17.88 17.29 16.69 15.37 14.20 13.13 Non Current Assets 10.17 10.58 11.18 9.72 9.94 10.37 9.77 9.56 Capital Work in Progress 0.00 0.00 0.00 0.00 0.00 0.10 0.57 0.34 Non Current Investment 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 Long Term Loans & Adv. 1.26 1.24 1.20 1.38 1.32 1.29 1.24 1.03 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 7.40 7.63 9.06 6.79 6.99 8.69 11.73 6.32 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 3.76 4.47 3.69 3.42 2.50 2.78 5.59 2.48 Sundry Debtors 3.01 2.47 4.72 2.77 3.77 5.18 5.15 3.05 Cash & Bank 0.08 0.10 0.05 -0.11 0.20 0.31 0.59 0.60 Other Current Assets 0.55 0.01 0.01 0.02 0.52 0.42 0.40 0.19 Short Term Loans & Adv. 0.52 0.58 0.58 0.68 0.49 0.39 0.39 0.18 Net Current Assets -1.37 -3.29 -0.86 1.70 1.62 1.05 3.75 -0.58 Total Assets 17.57 18.21 20.24 16.51 16.93 19.06 21.50 15.88

Description

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Shareholder's Funds

0.37

2.05

4.56

5.33

5.29

6.35

7.80

7.89

Share Capital

9.93

Total Reserves

-9.55

-7.88

-5.36

-4.60

-4.63

-3.58

-2.12

-2.04

Non-Current Liabilities

8.43

5.23

5.76

6.09

6.27

5.07

5.71

1.08

Secured Loans

0.00

0.02

0.08

0.00

0.22

Unsecured Loans

11.24

7.69

7.49

7.34

6.88

2.19

Long Term Provisions

0.00

Current Liabilities

8.77

10.92

9.91

5.09

5.37

7.64

7.99

6.91

Trade Payables

3.90

4.73

3.57

2.54

2.79

5.66

6.46

3.18

Other Current Liabilities

0.60

1.67

1.96

1.87

0.98

1.10

0.97

0.58

Short Term Borrowings

2.96

3.55

3.71

0.02

0.67

0.19

0.18

2.81

Short Term Provisions

1.32

0.98

0.67

0.66

0.93

0.70

0.38

0.33

Total Liabilities

17.57

18.20

20.23

16.51

16.93

19.06

21.50

15.88

Net Block

8.90

9.32

9.97

8.34

8.61

8.97

7.94

8.18

Gross Block

27.70

27.41

27.85

25.63

25.30

24.34

22.14

21.31

Accumulated Depreciation

18.80

18.09

17.88

17.29

16.69

15.37

14.20

13.13

Non Current Assets

10.17

10.58

11.18

9.72

9.94

10.37

9.77

9.56

Capital Work in Progress

0.00

0.10

0.57

0.34

Non Current Investment

0.01

Long Term Loans & Adv.

1.26

1.24

1.20

1.38

1.32

1.29

1.24

1.03

Other Non Current Assets

0.00

Current Assets

7.40

7.63

9.06

6.79

6.99

8.69

11.73

6.32

Current Investments

0.00

Inventories

3.76

4.47

3.69

3.42

2.50

2.78

5.59

2.48

Sundry Debtors

3.01

2.47

4.72

2.77

3.77

5.18

5.15

3.05

Cash & Bank

0.08

0.10

0.05

-0.11

0.20

0.31

0.59

0.60

Other Current Assets

0.55

0.01

0.02

0.52

0.42

0.40

0.19

Short Term Loans & Adv.

0.52

0.58

0.68

0.49

0.39

0.18

Net Current Assets

-1.37

-3.29

-0.86

1.70

1.62

1.05

3.75

-0.58

Total Assets

17.57

18.21

20.24

16.51

16.93

19.06

21.50

15.88

Cash Flow

Standalone Figures in Rs. Crores

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Cash From Operating Activity -1.92 0.80 -0.96 1.35 0.67 1.44 -0.56 0.34 PBT -2.01 -3.18 -1.18 0.04 -1.04 -1.45 -0.09 0.60 Adjustment 1.42 1.38 1.19 1.05 2.88 0.40 1.24 1.03 Changes in Working Capital -1.33 2.60 -0.97 0.26 -1.17 2.41 -1.71 0.86 Cash after chg. in Working capital -1.92 0.80 -0.96 1.35 0.67 1.35 -0.56 2.49 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.07 Tax Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.09 0.00 -2.09 Cash From Investing Activity -0.29 -0.08 -2.05 -0.34 -0.88 -1.75 -1.26 -1.01 Net Fixed Assets -0.29 0.44 -2.22 -0.33 -0.86 -1.73 -1.06 Net Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Others 0.00 -0.52 0.17 -0.01 -0.02 -0.02 -0.20 Cash from Financing Activity 2.18 -0.66 3.16 -1.32 0.10 0.02 1.81 0.04 Net Cash Inflow / Outflow -0.02 0.06 0.15 -0.31 -0.11 -0.28 -0.01 -0.62 Opening Cash & Equivalents 0.10 0.05 -0.11 0.20 0.31 0.59 0.60 1.23 Closing Cash & Equivalent 0.08 0.10 0.05 -0.11 0.20 0.31 0.59 0.60

Description

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Cash From Operating Activity

-1.92

0.80

-0.96

1.35

0.67

1.44

-0.56

0.34

PBT

-2.01

-3.18

-1.18

0.04

-1.04

-1.45

-0.09

0.60

Adjustment

1.42

1.38

1.19

1.05

2.88

0.40

1.24

1.03

Changes in Working Capital

-1.33

2.60

-0.97

0.26

-1.17

2.41

-1.71

0.86

Cash after chg. in Working capital

-1.92

0.80

-0.96

1.35

0.67

1.35

-0.56

2.49

Interest Paid

0.00

-0.07

Tax Paid

0.00

Other Direct Exp. Paid

0.00

Extra & Other Items

0.00

0.09

0.00

-2.09

Cash From Investing Activity

-0.29

-0.08

-2.05

-0.34

-0.88

-1.75

-1.26

-1.01

Net Fixed Assets

-0.29

0.44

-2.22

-0.33

-0.86

-1.73

-1.06

Net Investments

0.00

Others

0.00

-0.52

0.17

-0.01

-0.02

-0.20

Cash from Financing Activity

2.18

-0.66

3.16

-1.32

0.10

0.02

1.81

0.04

Net Cash Inflow / Outflow

-0.02

0.06

0.15

-0.31

-0.11

-0.28

-0.01

-0.62

Opening Cash & Equivalents

0.10

0.05

-0.11

0.20

0.31

0.59

0.60

1.23

Closing Cash & Equivalent

0.08

0.10

0.05

-0.11

0.20

0.31

0.59

0.60

Financial Ratios

Standalone

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Book Value (Rs.) 0.38 2.06 4.60 5.37 5.33 6.40 7.86 7.95 ROA -9.37% -13.07% -4.18% 0.23% -5.80% -7.17% -0.48% 0.50% ROE -138.44% -76.01% -15.52% 0.71% -17.93% -20.54% -1.13% 1.00% ROCE -9.18% -17.04% -4.06% 4.06% 3.99% -14.70% -0.42% 5.08% Fixed Asset Turnover 0.59 0.49 0.77 0.74 0.75 0.90 0.99 0.74 Receivable days 61.22 96.27 66.67 63.28 87.19 90.11 69.91 71.05 Inventory Days 91.89 109.16 63.20 57.29 51.45 73.03 68.83 57.75 Payable days 93.80 99.89 56.52 53.12 87.27 97.78 85.42 85.41 Cash Conversion Cycle 59.31 105.54 73.35 67.46 51.36 65.36 53.32 43.39 Total Debt/Equity 38.16 5.52 2.47 1.41 1.54 1.19 0.90 0.66 Interest Cover -1.77 -3.58 -0.97 0.80 1.01 -4.74 -1.96 9.83

Description

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Book Value (Rs.)

0.38

2.06

4.60

5.37

5.33

6.40

7.86

7.95

ROA

-9.37%

-13.07%

-4.18%

0.23%

-5.80%

-7.17%

-0.48%

0.50%

ROE

-138.44%

-76.01%

-15.52%

0.71%

-17.93%

-20.54%

-1.13%

1.00%

ROCE

-9.18%

-17.04%

-4.06%

4.06%

3.99%

-14.70%

-0.42%

5.08%

Fixed Asset Turnover

0.59

0.49

0.77

0.74

0.75

0.90

0.99

0.74

Receivable days

61.22

96.27

66.67

63.28

87.19

90.11

69.91

71.05

Inventory Days

91.89

109.16

63.20

57.29

51.45

73.03

68.83

57.75

Payable days

93.80

99.89

56.52

53.12

87.27

97.78

85.42

85.41

Cash Conversion Cycle

59.31

105.54

73.35

67.46

51.36

65.36

53.32

43.39

Total Debt/Equity

38.16

5.52

2.47

1.41

1.54

1.19

0.90

0.66

Interest Cover

-1.77

-3.58

-0.97

0.80

1.01

-4.74

-1.96

9.83

Norris Medicines Ltd.

Pharmaceuticals & Drugs

BSE: 524414 | NSE: Not Listed

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Annual Reports:

News Update

Norris Medicines Ltd.

Pharmaceuticals & Drugs

BSE: 524414 | NSE: Not Listed

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Annual Reports:

News Update